The global muscle stimulator market size is anticipated to reach USD 997.3 million by 2030, registering a CAGR of 3.5% over the forecast period, according to a new report by Grand View Research, Inc. The growing prevalence of musculoskeletal disorders and increasing demand for pain management therapies are the key factors driving the growth over the forecast period. Moreover, growing purchasing power, increasing healthcare expenditure, and technological innovations in medical devices are also driving the market growth.
Based on product type, Transcutaneous Electrical Nerve Stimulation (TENS) dominated the global market in 2019. Increasing demand for portable stimulation devices that can be operated at home and rising geriatric population that is prone to develop musculoskeletal disorders are the major factors driving the market growth. On the other hand, Neuromuscular Electrical Stimulation (NES) is estimated to be the fastest-growing segment during the forecast period owing to increasing cases of strokes and spinal cord injuries.
Based on modality, the market is segmented into portable, handheld, and tabletop. Portable stimulator dominated the muscle stimulator space in 2019, owing to the ease of carrying them while traveling and higher purchasing power in the hands of consumers. The segment is also anticipated to grow at the fastest rate of 4.2% during the forecast period. Key players launching innovative portable muscle stimulator devices to sustain market competition is also a major factor driving the segment growth.
Based on applications, the muscle stimulator market is segmented into pain management, neurological disorders, musculoskeletal disorders, and others. The pain management segment dominated the market with a share of 54.5% in 2019 and is anticipated to be the fastest growing segment during the forecast period. Increasing cases of chronic and acute pain and the need for effective pain management therapies among cancer patients are the major factors driving the growth over the forecast period.
Request a free sample copy or view report summary: Muscle Stimulator Market Report
The global market is anticipated to reach USD 997.3 million by 2030 owing to rising prevalence of musculoskeletal disorders and increasing demand for pain management therapies
Transcutaneous Electrical Nerve Stimulation (TENS) dominated the muscle stimulator market in 2022, owing to an increase in the demand for portable stimulator
Portable devices are estimated to witness the fastest growth, as their usage in muscle atrophy, relaxation of muscle spasms, and managing chronic pain is increasing
In 2022, the pain management application segment dominated the market with a share of 54.5% owing to increasing usage of muscle stimulator in the management of chronic and acute pain
Grand View Research has segmented the global muscle stimulator market based on product, modality, application, end-use, and region:
Muscle Stimulator Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Neuromuscular Electrical Stimulation
Functional Electrical Stimulation
Transcutaneous Electrical Nerve Stimulation
Interferential
Burst Mode Alternating Current
Micro Current Electrical Neuromuscular Stimulator
Others
Muscle Stimulator Modality Outlook (Revenue, USD Million, 2018 - 2030)
Handheld
Portable
Table Top
Muscle Stimulator Application Outlook (Revenue, USD Million, 2018 - 2030)
Pain Management
Neurological Disorder
Musculoskeletal Disorder
Others
Muscle Stimulator End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Physiotherapy Clinics
Sports Clinics
Home Care
Muscle Stimulator Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List Of Key Players in the Muscle Stimulator Market
NeuroMetrix, Inc.
OMRON Corporation
BioMedical Life Systems, Inc.
Zynex, Inc.
EMS Physio Ltd.
DJO Global, Inc.
Beurer GmbH.
"The quality of research they have done for us has been excellent..."